Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.03 USD | +2.54% | +2.45% | +8.48% |
15/05 | Transcript : Xencor, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 01:40 PM | |
10/05 | Wedbush Adjusts Xencor's Price Target to $36 From $34, Keeps Outperform Rating | MT |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
1.38B | - | - | - | |||
114B | ||||||
104B | ||||||
22.41B | - | |||||
22.28B | - | |||||
19.07B |
- Stock Market
- Equities
- XNCR Stock
- Charts Xencor, Inc.
- Sector Chart